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Background: The RGD motif in the mosquito-borne flaviviruses envelope protein domain III (EDIII) FG loop was
shown to bind negatively charged cellular molecules and mediate virus entry in mammals. However, its importance in
virus entry in the mosquito has not yet been defined. The sequences of RGD motifs are conserved in JEV-serocomplex
members primarily transmitted by Culex mosquitoes but absent from members of the DENV serocomplex, which utilize
Aedes mosquitoes as vectors. Interestingly, the RGD sequence is present in the attenuated 17D strain of yellow fever
virus as a result of the T380R mutation in the EDIII of Asibi strain following extensive in vitro passage in mice and
chicken embryos and was found to contribute to the more rapid clearance in mice challenged with 17D. However, viral
infectivity and dissemination in mosquitoes had not been evaluated for this mutant.
Findings: The study utilized the reverse genetics system of YFV and Ae. aegypti RexD WE mosquitoes to assess the
impact of a T380R mutation in YFV Asibi and 17D/Asibi M-E chimera. The T380R mutation led to higher infection rates
but similar dissemination rates when introduced into the YFV Asibi strain and 17D/Asibi M-E chimera.
Conclusions: While the increase of the positive charge in EDIII may reduce the virulence of YFV in mice, this mutation
favored the establishment of the viral infection in Ae. aegypti. However, such gain in viral infectivity did not increase
dissemination in infected mosquitoes.
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The transmission cycles of flaviviruses require successful
utilization of cellular receptors in a wide variety of
organisms including mammals, avians or arthropods.
Although several molecules of mammalian origin have
been proposed as putative receptors for mosquito-
borne flaviviruses, knowledge about arthropod recep-
tors remains limited [1]. Flavivirus receptor-binding
activity in mammals was first shown to be mediated by
the domain III of envelope protein (EDIII), eventually
localized to the FG loop [2,3]. Although the sequences
and structures of the FG loop among mosquito-borne
and tick-borne flaviviruses are largely conserved, minor
differences were still observed in the FG loop not only* Correspondence: shiggs@bri.ksu.edu
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unless otherwise stated.between both types of flaviviruses but also among
mosquito-borne flaviviruses that utilize different vector
species. Interestingly, the FG loops of mosquito-borne fla-
vivirus EDIII are invariably longer than those of tick-borne
flavivirus EDIII, which lack the RGD (Arg-Gly-Asp) motif.
Inhibition of virus entry by peptides resembling the
DENV-2 FG loop in mosquito cells in vitro first sug-
gested its role in determining vector specificity [3].
Alignment of the amino acid sequences of mosquito-
borne flaviviruses further demonstrated the RGD motif,
especially the Arg and Gly residues, was largely conserved
in the mosquito-borne flaviviruses in the JEV serocomplex,
which utilize a substantially larger spectrum of host and
vector species than other flaviviruses [4,5]. However,
attenuated YFV 17D strains have the RGD motif while
the virulent Asibi parental strain contains a Thr instead
of Arg at position 380 [4]. These data highlight the need
for understanding the function of the conserved Arg
residue, which has been identified as a determinant of
binding efficiency to negatively charged host moleculesLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Ae. aegypti infection rates, calculated as number infected whole mosquitoes and bodies/tested
Average blood meal titer (logTCID50/ml) 7 d.p.i. 10 d.p.i. 14 d.p.i.
Defibrinated sheep blood N.A. 0/30 (0.0%) 0/24 (0.0%) 0/35 (0.0%)
17D 6.24 9/25 (36.0%) 8/12 (66.7%) 8/32 (25.0%)
17D/Asibi M-E 5.77 12/29 (41.4%) 13/24 (54.2%) 21/39 (53.8%)
17D/Asibi M-E E T380R 5.85 21/23 (91.3%)† 10/12 (83.3%) 14/16 (87.5%)†
Asibi 3.99 20/33 (60.6%) 9/18 (50.0%) 21/38 (52.6%)
Asibi E T380R 4.21 32/48 (66.7%) 21/36 (58.3%) 21/39 (53.8%)
†indicates the significant difference by Fisher’s exact test from 17D/Asibi M-E chimera.
Table 2 Ae. aegypti dissemination rates calculated as
positive secondary tissues/tested
7 d.p.i. 10 d.p.i. 14 d.p.i.
17D 0/3 (0.0%) 1/5 (20.0%) 0/12 (0.0%)
17D/Asibi M-E 2/6 (33.3%) 3/8 (37.5%) 7/14 (50.0%)
17D/Asibi M-E E T380R 3/14 (21.4%) 1/6 (16.7%) 5/8 (62.5%)
Asibi 8/17 (47.1%) 4/5 (80.0%) 9/15 (60.0%)
Asibi E T380R 15/19 (79.0%) 9/14 (64.3%) 10/15 (66.7%)
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RGD motif has been performed in JEV, WNV, MVEV and
YFV in mice, knowledge of its interaction with arthropod
receptors remains limited [6-8]. Length of the correspond-
ing region in DENV-2 EDIII played a more significant role
than the sequence in infectivity, and substitution with the
sequence of YFV 17D strain did not significantly decrease
infectivity in Aedes aegypti. However, the sequence of YFV
Asibi strain, which is more infectious and disseminates at
higher rates in Ae. aegypti, was not evaluated [9-11]. More
importantly, this model provided limited information on
the RGD motif function due to the lack of conservation of
this motif among the four DENV serotypes. Therefore, we
utilized the YFV reverse genetics system to evaluate the
impact of the Thr380Arg (T380R) mutation in EDIII on
the viral infectivity and dissemination in Ae. aegypti. Such
knowledge will increase understanding of the RGD-mo
tif-dependent viral entry mechanisms among mosquito-
borne flaviviruses utilizing different vectors.
Introduction of T380R mutation in E of infectious
clones of YFV Asibi strain and 17D/Asibi M-E chimera
was achieved by subcloning the structural genes into the
pGEM®-T Easy vector (Promega, Madison, WI) followed
by PCR site-directed mutagenesis with Quikchange®II XL
kit (Stratagene, La Jolla, CA) and ligation of BspEI (New
England Biolabs, Ipswich, MA)- and MluI (New England
Biolabs)- digested plasmids as previously described [12].
Rescued viruses were obtained via electroporation of
in vitro transcribed viral RNA in BHK-21 cells main-
tained in MEM-α media (Life technologies, Carlsbad,
CA) supplemented with 10% FBS (Life technologies).
Freshly harvested viruses mixed with defibrinated sheep
blood were presented to 6 to 8-day-old Ae. aegypti RexD
WE strain through a Hemotek membrane feeding appar-
atus (Discovery Workshop, Lancashire, England UK) at
37C for 60 minutes. Engorged mosquitoes were main-
tained with 10% sucrose solution at 16 hr:8 hr light–dark
photoperiod for 14 days. Mosquitoes were cold anesthe-
tized and dissected to collect the body and secondary
tissues including the head, wings and legs of individual
mosquitoes at 7, 10, and 14 days post infection (d.p.i.).
The secondary tissues were used as the indicator for viral
dissemination based on the disseminating phenotypes ofthe Asibi strain which causes the presence of infectious vi-
ruses in the head, wings and legs after the establishment
of infection in the midgut [13]. Viral replication kinetics
were assessed by titration of homogenized whole mosqui-
toes by TCID50 as described previously [10]. Infection was
defined as the positive immunofluorescence staining in
the serially-diluted homogenates of whole mosquito, body
or secondary tissues in Vero cells. Dissemination was de-
fined by the positive immunofluorescence staining in the
homogenates derived from the secondary tissues in Vero
cells. Fisher’s exact test was used to analyze the infection
and dissemination rates and ANOVA was performed for
the analysis of the titers of infected whole mosquitoes.
The infection and dissemination rates for all groups
are summarized in Tables 1 and 2, respectively. The
T380R mutation did not abolish viral infectivity, as simi-
lar infection rates of Asibi strain and Asibi E T380R mu-
tant were observed at 7 (60.6% vs. 66.7%), 10 (50%
vs.58.3%) and 14 (55.3% vs. 53.8%) d.p.i. Interestingly, a
significantly higher infection rate was observed for the
17D/Asibi M-E E T380R mutant compared to the wild-
type 17D/Asibi M-E chimera at 7 d.p.i. (91.3% vs. 41.4%,)
and 14 d.p.i. (87.5% vs. 53.8%) (p < 0.05) although infection
rates were not significantly higher at 10 d.p.i. The estab-
lishment of infection also led to similar dissemination
rates both between the Asibi strain and Asibi E T380R
mutant and between the 17D/Asibi M-E chimera and
17D/Asibi M-E E T380R mutant at 7, 10 and 14 d.p.i.
Virus titers in whole mosquitoes were not significantly
different for any group (Figure 1).
Our results demonstrated the change in the biochem-
ical properties between Thr and Arg did not reduce the
viral infectivity and subsequent dissemination of YFV in
Figure 1 Titers of whole-mosquito homogenates of Ae. aegypti at 7, 10 and 14 d.p.i.
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infect a significantly higher percentage of mosquitoes at
7 and 14 d.p.i. than the 17D/Asibi M-E chimera, which
was previously shown to have the lower infectivity due
to the attenuation by the chimerization [12]. However,
the results showed the likelihood of transmission should
not be enhanced due to the similar dissemination rates
between the wild-type and mutant viruses. The obser-
vation was partially consistent with the previously pub-
lished study on DENV-2 based on the fact that the
infectivity was maintained whilst the length of FG-loop
was not altered. The more plausible explanation for the
increased infectivity due to the T380R mutation may be
that the gain of positive charge leads to the more effi-
cient viral attachment to the target cells in the host and
the higher infection rates. Although the increase of posi-
tive charges on viral structural proteins has been known
to reduce the viral dissemination, most mutant viruses
still retain the infectivity for susceptible host cells. The
presence of the positive charges on the E2 glycoprotein
of the mosquito-borne alphavirus eastern equine en-
cephalitis virus led to the higher number of infected
brain cells in mice intracerebrally challenged, indicating
the presence of positively charged amino acids may be
advantageous for the establishment of infection [14]. In
the case of adeno-associated virus, the gain of positive
charge through the similar Thr➔Arg mutation in the
capsid region significantly increased the viral attachmentto HeLa cells [15]. Our results suggest that the presence
of the positively charged arginine on the FG loop may favor
the establishment of infection in mosquitoes. Understand-
ing the function of flavivirus RGD motifs and FG loops in
viral infection and dissemination can only be achieved by
further testing the hypothesis with the reverse genetics sys-
tems of Culex-borne flaviviruses, tick-borne flaviviruses and
the newly discovered mosquito-only flaviviruses.Competing interests
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